MUMBAI, India, April 11 -- Intellectual Property India has published a patent application (202517005205 A) filed by Mirati Therapeutics, Inc., Princeton, U.S.A., on Jan. 22, for 'salts of sos1 inhibitors.'
Inventor(s) include Marx, Matthew, Arnold; Ketcham, John, Michael; Smith, Christopher, Ronald; Lawson, John, David; Burns, Aaron, Craig; Wang, Xiaolun; Kulyk, Svitlana; and Ivetac, Anthony.
The application for the patent was published on April 11, under issue no. 15/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to compounds that inhibit Son of sevenless homolog 1 (SOS1) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and metho...